Literature DB >> 32672514

Pseudomonas aeruginosa Can Degrade Interferon λ, Thereby Repressing the Antiviral Response of Bronchial Epithelial Cells.

Adeline Peignier1, Dane Parker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32672514      PMCID： PMC7461995          DOI： 10.1089/jir.2020.0057

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN： 1079-9907            Impact factor:   3.657


× No keyword cloud information.
  19 in total

Review 1.  Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis.

Authors:  Laura J Sherrard; Michael M Tunney; J Stuart Elborn
Journal:  Lancet       Date:  2014-08-23       Impact factor: 79.321

2.  Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections.

Authors:  Dao Nguyen; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

3.  Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha.

Authors:  R Pellizzari; C Guidi-Rontani; G Vitale; M Mock; C Montecucco
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

4.  Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrea Faris; Adam Comstock; Wai-Ming Lee; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

Review 5.  Treatment of pulmonary exacerbations in adult cystic fibrosis patients: a review.

Authors:  Tara Lynn Barto; Patrick A Flume
Journal:  Hosp Pract (1995)       Date:  2010-02

Review 6.  Interactions Between NS1 of Influenza A Viruses and Interferon-α/β: Determinants for Vaccine Development.

Authors:  Ben X Wang; Eleanor N Fish
Journal:  J Interferon Cytokine Res       Date:  2017-05-17       Impact factor: 2.607

7.  Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8.

Authors:  E DiMango; H J Zar; R Bryan; A Prince
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 8.  Interferon Lambda: Modulating Immunity in Infectious Diseases.

Authors:  Mohammedyaseen Syedbasha; Adrian Egli
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

9.  Arterivirus nsp4 Antagonizes Interferon Beta Production by Proteolytically Cleaving NEMO at Multiple Sites.

Authors:  Jiyao Chen; Dang Wang; Zheng Sun; Li Gao; Xinyu Zhu; Jiahui Guo; Shangen Xu; Liurong Fang; Kui Li; Shaobo Xiao
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

10.  Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses.

Authors:  Shantelle L LaFayette; Daniel Houle; Trevor Beaudoin; Gabriella Wojewodka; Danuta Radzioch; Lucas R Hoffman; Jane L Burns; Ajai A Dandekar; Nicole E Smalley; Josephine R Chandler; James E Zlosnik; David P Speert; Joanie Bernier; Elias Matouk; Emmanuelle Brochiero; Simon Rousseau; Dao Nguyen
Journal:  Sci Adv       Date:  2015-07-31       Impact factor: 14.136
View more
  1 in total

1.  Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2.

Authors:  P G Madonov; V A Svyatchenko; S S Legostaev; N A Kikhtenko; A A Kotlyarova; L A Oleinik; G I Baikalov
Journal:  Bull Exp Biol Med       Date:  2021-11-18       Impact factor: 0.804
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.